Non-Billable / Non-Specific Code
ICD-10-CM C7A is the diagnosis code for Malignant neuroendocrine tumors. This code falls under the section "Malignant neuroendocrine tumors" within Chapter 2 â Neoplasms (C00-D49). It is a non-billable/non-specific ICD-10-CM code that should not be used for reimbursement. A more specific sub-code is required for billing. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
The following conditions are not included in C7A. If the patient has both, code each condition separately:
Understanding where C7A sits in the ICD-10-CM classification helps ensure proper coding:
No, C7A is a non-billable/non-specific code. You should use a more specific sub-code for billing and reimbursement.
C7A is the ICD-10-CM diagnosis code for "Malignant neuroendocrine tumors". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
C7A is located in Section C7A â "Malignant neuroendocrine tumors" within Chapter 2 of the ICD-10-CM Tabular List.
C7A has 3 sub-code(s) that provide more specific detail: C7A.0, C7A.1, C7A.8.
Use C7A when the patients documented diagnosis matches "Malignant neuroendocrine tumors" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Malignant neuroendocrine tumors is C7A.
No, C7A is non-billable. Use a more specific sub-code for primary diagnosis billing.
C7A is in Chapter 2 of the ICD-10-CM Tabular List.
Yes, C7A is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.